Global Peptide Synthesis Market – Industry Trends and Forecast to 2030

Peptide Synthesis Market Analysis and Size   

Peptide synthesis is the process of chemically creating peptides by combining amino acids in a specific order. It is used in pharmaceutical research for developing new drugs and studying their interactions. It enables the production of custom-designed peptides for studying protein structure and function, as well as creating peptide-based therapies and diagnostics. Peptide synthesis also aids in high-throughput screening and drug discovery efforts.

Data Bridge Market Research analyses that the Peptide synthesis Market which was USD 4.7 billion in 2022, would rocket up to USD 8.82 billion by 2030, and is expected to undergo a CAGR of 8.20% during the forecast period. “Therapeutics” dominates the application segment of the peptide synthesis market owing to the growing use of peptides for various disease conditions. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Peptide Synthesis Market Scope and Segmentation

Market Definition

Peptide synthesis refers to the chemical process of creating peptides, which are short chains of amino acids linked together by peptide bonds. It involves the stepwise assembly of amino acids in a specific order and often requires the protection of certain functional groups to control the reaction. Peptide synthesis can be achieved through various methods, such as solid-phase synthesis, solution-phase synthesis, or recombinant DNA technology. The goal of peptide synthesis is to produce peptides with precise sequences and desired modifications for various applications, including research, drug development, diagnostics, and therapeutics.

Peptide Synthesis Market Dynamics

Drivers

• Increasing demand for peptide-based therapeutics

Peptides offer unique advantages as therapeutics, such as high specificity, low toxicity, and favorable pharmacokinetic properties. The growing prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is driving the demand for peptide-based drugs. The development of innovative peptide therapeutics and the need for efficient peptide synthesis methods are key drivers for the market.

• Expanding applications in diagnostics and imaging

Peptides play a crucial role in diagnostic applications, including the development of peptide-based biosensors, imaging agents, and biomarker. The rising demand for non-invasive and targeted diagnostic tools, such as peptide-based imaging agents for molecular imaging and peptide-based biosensors for disease detection, is driving the market growth.

Opportunities

• Advancement in therapeutics for rare diseases

Peptides offer potential solutions for treating rare genetic disorders and orphan diseases. The growth of the peptide synthesis market provides an opportunity to develop and manufacture peptide-based therapeutics targeting these conditions. Companies can focus on designing and synthesizing peptides that address specific molecular targets associated with rare diseases, thereby catering to unmet medical needs.

• Personalized medicine and precision therapeutics

Peptides can be tailored to specific patient profiles, leading to the concept of personalized medicine. With advances in genomics, proteomics, and bioinformatics, there is an opportunity for peptide synthesis companies to develop customized peptide therapies that match individual patient characteristics, such as genetic mutations or protein expression patterns. This approach can lead to more effective and targeted treatment strategies.

Restraints/Challenges

• Purification and quality control

Obtaining peptides of high purity is crucial for their successful application in research and therapeutics. Purification methods, such as high-performance liquid chromatography (HPLC), can be time-consuming and require optimization for each peptide sequence. Quality control measures are essential to ensure the accuracy, consistency, and safety of synthesized peptides. Maintaining high-quality standards and efficient purification processes can be a challenge for the peptide synthesis market.

This peptide synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the peptide synthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In May 2023, PolyPeptide, a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs), and Numaferm, a German biotech company specialized in process development and production of peptides and proteins, have signed a Preferred Partner Collaboration Agreement for peptide development and production, leveraging PolyPeptide’s cGMP manufacturing capacities, regulatory know-how and market access and Numaferm’s biochemical production platform and expertise in sustainable peptide manufacturing.
• In June 2023, IRBM, an innovative contract research organization, today announced it has signed a new agreement with Merck & Co. Inc., Rahway NJ USA, known as MSD outside the USA and Canada, to continue their collaboration in the peptide therapeutics area.

Global Peptide synthesis Market Scope

The peptide synthesis market is segmented on the basis of type, product, technology, application, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Under 75%
• 75-85%
• Above 85%

Product

• Equipment
• Reagents and Consumables
• Others

Technology

• Solid-Phase Peptide Synthesis (SPPS)
• Solution-Phase Synthesis (SPS)
• Liquid-Phase Peptide Synthesis (LPPS)
• Hybrid and Recombinant

Application

• Therapeutics
• Diagnosis
• Research

End-User

• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Organization (CMO) or Contract Research Organization (CRO)
• Academic and Research Institutes

Peptide synthesis Market Regional Analysis/Insights

The peptide synthesis market is analysed and market size insights and trends are provided by country, type, product, technology, application, and end user referenced above.

The countries covered in the peptide synthesis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the peptide synthesis market due to the sturdy occurrence of major key players. Furthermore, the rise in the alertness regarding the accessible peptide synthesis technologies and the rising attention on moving the peptide drugs on a commercial scale will further boost the growth of the peptide synthesis market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth of the peptide synthesis market due to the rise in the investments by major key players. Moreover, the increasing consciousness regarding the novel peptide treatments and the growing healthcare expenditure is further anticipated to propel the growth of the peptide synthesis market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Peptide synthesis Market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Peptide synthesis Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Peptide synthesis Market. The data is available for historic period 2010-2020.

Competitive Landscape and Peptide synthesis Market Share Analysis

The peptide synthesis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the peptide synthesis market are:

• PolyPeptide Group (Belgium)
• Merck KGaA (Germany)
• Thermo Fisher Scientific (U.S.)
• Enamine Ltd (Ukraine)
• Alfa Chemistry (China)
• CEM Corporation (U.S.)
• GenScript (U.S.)
• AAPPTec (U.S.)
• Bachem Holding (Switzerland)
• AnaSpec, Inc. (U.S.)
• Biotage (Sweden)
• GYROS PROTEIN TECHNOLOGIES AB (Sweden)
• Advanced ChemTech (U.S.)
• New England Peptide, Inc. (U.S.)
• Guizhou Xinbang Pharmaceutical Co., Ltd. (China)
• Hybio Pharmaceutical Co., Ltd. (China)
• USV Private Limited (India)
• ScinoPharm Taiwan (Taiwan)
• CPC Scientific Inc. (U.S.)

SKU-47961